193 results on '"Braun, Andrew"'
Search Results
2. Knowledge, attitudes, and practices of Jamaican healthcare workers on nosocomial infection control
3. Regional Anesthesia for Arthroscopic Knee Repair in a Patient With Hypertrophic Obstructive Cardiomyopathy (HOCM) Under Monitored Anesthesia Care With Dexmedetomidine Infusion
4. Vitamin D status and variable responses to supplements depend in part on genetic factors in adults with cystic fibrosis
5. Current Review of the Use of Intrathecal Morphine for Postoperative Analgesia in Total Joint Arthroplasty
6. Comparison of Pericapsular Nerve Group (PENG) Block Versus Quadratus Lumborum (QL) Block for Analgesia After Primary Total Hip Arthroplasty Under Spinal Anesthesia: A Retrospective Study
7. Cellular and Ionic Mechanisms of Arterial Vasomotion
8. Administration of the KCa channel activator SKA-31 improves endothelial function in the aorta of atherosclerosis-prone mice
9. Loss- and gain-of-function mutations in the Type 1 IP3 receptor (IP3R1) affect myogenic constriction of murine cerebral resistance arteries
10. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials
11. Endothelial KCa channels: Novel targets to reduce atherosclerosis-driven vascular dysfunction
12. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials
13. Perinatal outcomes in patients with biopsy confirmed sarcoidosis
14. Can KCa3.1 channel activators serve as novel inhibitors of platelet aggregation?
15. Compact Range Measurements of Digital Arrays Leading to Outdoor RADAR Experiments
16. Interrater Reliability of the Simulation Fidelity (SiFi) Scale
17. The Alzheimer risk factor CD2AP causes dysfunction of the brain vascular network
18. Modification of Fibronectin by Non-Enzymatic Glycation Impairs K+ Channel Function in Rat Cerebral Artery Smooth Muscle Cells
19. Enhancement of Endothelial KCa Channel Activity as a Novel Strategy to Oppose Atherosclerosis
20. Using A Work System Framework to Investigate Pharmacists' Roles in Cystic Fibrosis Management
21. Regional Variation in Arterial Myogenic Responsiveness: Links to Potassium Channel Diversity/Function
22. Effects of Pharmacological Inhibitors of NADPH Oxidase on Myogenic Contractility and Evoked Vasoactive Responses in Rat Resistance Arteries
23. A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment
24. Characterizing medication management and the role of pharmacists in caring for people living with cystic fibrosis: A work system approach
25. Enhancement of Endothelial KCa Channel Activity as a Novel Strategy to Oppose Atherosclerosis
26. Exploring Endothelial KCa Channel Activation as a Novel Strategy to Restore Cardiac Function Following Acute Myocardial Infarction in Mice
27. Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis
28. KCa channel activation normalizes endothelial function in Type 2 Diabetic resistance arteries by improving intracellular Ca2+ mobilization
29. The Alzheimer risk factor CD2AP causes dysfunction of the brain vascular network
30. Effects of nasal high flow on nocturnal hypercapnia, sleep, and sympathovagal balance in patients with neuromuscular disorders
31. Immediate Repair of a Complete Uterine Transection After Motor Vehicle Collision
32. Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension
33. Effects of In Vivo Administration of an Endothelial KCa Channel Activator on Recovery of Cardiac Function Following Acute Myocardial Infarction in Mice
34. Loss‐ and Gain‐of‐Function Mutations in the Type 1 IP3 Receptor (IP3R1) Affect Myogenic Constriction of Cerebral Resistance Arteries in Response to Intraluminal Pressure
35. Loss‐ And Gain of Function Mutations in the Type 1 IP3 Receptor (IP3R1) Modify Agonist‐Evoked Vasoactive Responses in Cerebral and Skeletal Muscle Resistance Arteries From Adult Mice
36. Data-Driven Solutions for Digital Communications
37. Performance Analysis of Reference Oscillators and Frequency Synthesizers for use in High-Fidelity Satellite Navigation Receivers
38. Applying whole-genome sequencing in relation to phenotype and outcomes in siblings with cystic fibrosis
39. SKA-31, an activator of Ca2+-activated K+ channels, improves cardiovascular function in aging
40. Lrrc55 is a novel prosurvival factor in pancreatic islets
41. RELAPSING LUNG INJURY: A SEVERE MANIFESTATION OF SLEEP-RELATED EATING DISORDER
42. Pharmacological Targeting of KCa Channels to Improve Endothelial Function in the Spontaneously Hypertensive Rat
43. Prolonged Administration of the KCa Channel Activator SKA‐31 Improves Cardiac Function and Blood Pressure in Type 2 Diabetic Goto‐Kakizaki Rats
44. In Vivo Targeting of the Endothelium to Improve Vascular Function in a Rodent Model of Type 2 Diabetes
45. Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer
46. SKA-31, an activator of endothelial Ca 2+ -activated K + channels evokes robust vasodilation in rat mesenteric arteries
47. Abstract 3792: Intratumoral CD56brightnatural killer cells are associated with improved survival in bladder cancer
48. Amyotrophic Lateral Sclerosis and the Respiratory System
49. Intratumoral CD56bright Natural Killer cells are associated with improved survival in bladder cancer
50. Reductions in dead space ventilation with nasal high flow depend on physiological dead space volume: metabolic hood measurements during sleep in patients with COPD and controls
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.